Fingerprint
Dive into the research topics of 'Cisplatin, irinotecan, and bevacizumab for untreated extensive-stage small-cell lung cancer: CALGB 30306, a phase II study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Cisplatin, irinotecan, and bevacizumab for untreated extensive-stage small-cell lung cancer: CALGB 30306, a phase II study
Neal E. Ready, Arkadiusz Z Dudek, Herbert H. Pang, Lydia D. Hodgson, Stephen L. Graziano, Mark R. Green, Everett E. Vokes
Research output: Contribution to journal › Article › peer-review
74
Scopus
citations